Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05130437 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study

StatusRecruiting
PhasePhase 1/2
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 12 to 22v14
  2. Primary endpoints: 2 to 1v13 Show 4 more changesShow less
    • Enrollment target: 36 to 50
    • Eligibility criteria expanded, about 19 words
    • Secondary endpoints: 14 to 4
    • Study description shortened, about 6 words
  3. Study sites: 9 to 12v12
  4. Re-verified, no change to tracked fieldsv11
  5. Study sites: 6 to 9v10
Show 8 earlier versionsHide 8 earlier versions
  1. Primary endpoints: 1 to 2
    • Secondary endpoints: 10 to 14
    • Study sites revised (6)
    • Study title expanded, about 7 words
    v9
  2. Study sites: 7 to 6v8
  3. Study sites: 5 to 7v7
  4. Re-verified, no change to tracked fieldsv6
  5. Study sites: 4 to 5v5
  6. Study sites: 2 to 4v4
  7. Study sites: 1 to 2v3
  8. Re-verified, no change to tracked fieldsv2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Moderna
49 trials monitored
See 3 trials at risk
The main purpose of this study is to evaluate the long-term safety of mRNA-3927 administered to participants with propionic acidemia (PA) who have previously participated in Study mRNA-3927-P101 (NCT04159103).
Trial Details
NCT Number NCT05130437
Lead Sponsor ModernaTX, Inc.
Conditions
(from sponsor)		 Propionic Acidemia
Related terms Acid-Base Imbalance, Acidosis, Amino Acid Metabolism, Inborn Errors, Genetic Diseases, Inborn, Metabolic Diseases, Metabolism, Inborn Errors, Propionic Acidemia
Enrollment 50 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov